Y-90 MICROSPHERE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) PATIENT-DERIVED TUMOROIDS AND CELL LINES REVEALS HETEROGENEITY OF RESPONSE

被引：0
|
作者：
Malone, Christopher [1 ]
Zheleznyak, Alexander [1 ]
Sonnek, Naomi [1 ]
Sullentrup, Robert [1 ]
Blanc, Valerie [1 ]
Strnad, Benjamin S. [1 ]
Nix, Darren [1 ]
Liu, Xiuli [1 ]
Cliften, Paul [1 ]
Weber, Jason [1 ]
Fields, Ryan [1 ]
Ciorba, Matthew [1 ]
Davidson, Nicholas [2 ,3 ]
机构：
[1] Washington Univ, St Louis, MO USA
[2] Washington Univ, Sch Med, Dept Med, St Louis, MO USA
[3] Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4156-A
引用
收藏
页码：S1911 / S1911
页数：1
相关论文
共 50 条
  • [1] Yttrium-90 (Y-90) resin microsphere therapy for patients with unresectable hepatocellular carcinoma. Identification of successful treatment response predictors and patient selection
    Arslan, Nuri
    Ince, Semra
    Okuyucu, Kursat
    San, Huseyin
    Alagoz, Engin
    Karadurmus, Nuri
    Karaman, Bulent
    Ercin, Cemal Nuri
    ANNALI ITALIANI DI CHIRURGIA, 2021, 92 (06) : 623 - 631
  • [2] Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma
    Woerner, Andrew J.
    Johnson, Guy E.
    HEPATOMA RESEARCH, 2022, 8
  • [3] Patient-derived hepatocellular carcinoma organoids as predictors of Treatment Response
    Park, Jun Yong
    Cho, Kyung Joo
    Lee, Hye Won
    Park, Hye Jung
    Ahn, Sang Hoon
    Lee, Hee Seung
    Kim, Chul Hoon
    JOURNAL OF HEPATOLOGY, 2022, 77 : S755 - S755
  • [4] Efficacy of Y-90 microspheres in the treatment of unresectable hepatocellular carcinoma
    Ozhan, M.
    Nisli, S.
    Kabasakal, L.
    Gulsen, F.
    Cantasdemir, M.
    Pekmezci, S.
    Saribeyoglu, K.
    Numan, F.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S425 - S425
  • [5] Comparison study of the treatment of unresectable hepatocellular carcinoma with Y-90 SIR-Spheres and Y-90 TheraSphere
    Zhang, Zhuangyu
    Machac, Josef
    Heiba, Sherif
    Knesaurek, Karin
    Zaretsky, Victor
    Mihaila, Adrian
    Weintraub, Joshua
    Nowakowski, Scott
    Kim, Edward
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [6] Concordance of RECIST 1.1 with RECIST 1.0 in assessing response of hepatocellular carcinoma (HCC) treated with Y-90 microspheres
    Song, Chia Ghim
    Allen, John
    Shan, Lim Miao
    Choon, Lim Kheng
    Goh, Anthony
    Lo, Richard
    Low, Albert
    Poon, Donald
    Beng, Tan Say
    Chow, Pierce K. H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A141 - A142
  • [7] A Novel Patient-Based Dosimetric Approach for Y-90 Microsphere Treatment
    Cakir, F.
    Bozkurt, M. F.
    Ozden, A. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S480 - S480
  • [8] Molecular characterization of hepatocellular carcinoma (HCC) patient-derived explant models
    Zhang, Lan
    Zhang, Jingchuan
    Xie, Liang
    Xie, Xiaoying
    Guo, Qiuli
    Lv, Jing
    Gao, Zeren
    Qian, Ziliang
    Yin, Xiaolu
    Zheng, Li
    Zhu, Guanshan
    Ji, Qunsheng
    Ren, Zhenggang
    CANCER RESEARCH, 2011, 71
  • [9] Assessment of Y-90 Radioembolization Treatment Response for Hepatocellular Carcinoma Cases Using MRI Radiomics
    Mahmoud, Mennaallah
    Lin, Ko-Han
    Lee, Rheun-Chuan
    Liu, Chien-an
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2024, 33 (03) : 156 - 166
  • [10] HEPATOCELLULAR-CARCINOMA - PILOT TRIAL OF TREATMENT WITH Y-90 MICROSPHERES
    HOULE, S
    YIP, TCK
    SHEPHERD, FA
    ROTSTEIN, LE
    SNIDERMAN, KW
    THEIS, E
    CAWTHORN, RH
    RICHMONDCOX, K
    RADIOLOGY, 1989, 172 (03) : 857 - 860
12345